Aditya R. Pote

Also affiliated with AstraZeneca (United States)

ChemistryBiochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Synthetic Antibiotic Scaffold Effective Against Multidrug-Resistant Bacterial Pathogens”.

A Synthetic Antibiotic Scaffold Effective Against Multidrug-Resistant Bacterial Pathogens

ChemRxiv(2021)10.26434/chemrxiv.14331407

N/A

0.299DataRank · unranked

5 citations

Amarnath Pisipati, Egor A. Syroegin, Katherine J. Silvestre, Dorota Klepacki, J. F. A. MASON +10 more

A synthetic antibiotic class overcoming bacterial multidrug resistance

Nature(2021)10.1038/s41586-021-04045-6

N/A

0DataRank · unranked

234 citations

Amarnath Pisipati, Egor A. Syroegin, Katherine J. Silvestre, Dorota Klepacki, Jeremy D. Mason +10 more

A Synthetic Antibiotic Scaffold Effective Against Multidrug-Resistant Bacterial Pathogens

ChemRxiv(2021)10.26434/chemrxiv.14331407.v1

N/A

0DataRank · unranked

4 citations

Amarnath Pisipati, Egor A. Syroegin, Katherine J. Silvestre, Dorota Klepacki, J. F. A. MASON +10 more